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Aside from the obvious function of skin to
serve as a protective envelope for the body's
contents, skin has been shown to engage in
a variety of biochemical activities (1—8).
Among these, the metabolism of steroid
hormones is of special interest since the
epidermis and its appendages respond to
stimulation by some of these hormones. The
effects of estrogen on vaginal mucosa, testos-
terone on sebaceous glands and hair follicles,
and corticosteroids on inflammed skin are well
known. Both cortisol and testosterone were
found to be actively metabolized by human
skin (3, 4, 8, 9, 10), and the interconversion
of estrone and 17/3-estradiol in human skin
was reported in a preliminary communication
from this laboratory (6). In further studies,
the metabolism of the two estrogens in vaginal
mucosa, a "target" tissue, was compared With
that in abdominal skin and foreskin, "non-
target" tissues. This report provides informa-
tion regarding regional variations in metabo-
lism of 17/3-estradiol and estrone, differences
iii activity between epidermis and dermis,
and cofactor requirements for these reactions.
MATERIALS AND METHODS
Irteuba lion mixture—Foreskin specimens were
obtained from neonatal infants by circumcision.
Abdominal skin was obtained at surgery from four
females and two males, free of endocrine abnor-
malities, between the ages of 22—61. Vaginal mu-
cosa was obtained from seven patients 20—66 years
old who underwent hysterectomies or other gyne-
cological surgery. Specimens of skin were kept at
5—10° C and used within 1—2 hours. After removal
of subcutaneous fat the specimens were minced
with scissors and pooled. 17fi-Estradiol-4-'4C (31.8
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rnc/mrnole) and estrone-44C (33.7 mc/mmole)
were purchased from Nuclear Chicago and puri-
fied by paper chromatography in system I as de-
scribed below. The minced skin (200 mg) was
incubated in 5 ml of Krebs-Ringer phosphate
buffer, pH 7.4, with either of the radioactive es-
trogens (3.0 X 10 to 6.0 X 10 dpm of "C, 025
tmole) added in 0.05-0.15 ml of methanol. NAD,
NADH, NADP, and NADPH, were purchased
from Sigma Chemical Co. and 5 cmoles of each
were added in the specified experiments. The mix-
tures were incubated for 5 hours in a Dubnoff
shaker at 37° C.
Recovery of radioactivity—The incubations
were terminated by the addition of 15 ml of meth-
anol-methylene chloride (2:1), and the radioactive
materials were recovered by repeated extraction
with methylene chloride according to a previously
published procedure (6). The amount of '4C re-
covered was 80% of that incubated.
Identification of metabolites—17p-Estradiol and
estrone were purchased from Mann Research Lab-
oratories, recrystallized from acetone-hexane and
used as reference compounds in chromatography
and as carriers for reverse isotopic dilutions.
The methylene chloride extracts from the incu-
bations were evaporated under vacuum and the
residues applied to paper strips (Whatman No. 1,
1 >< 25 inches). The chrornatograms were devel-
oped for 3—5 hours in benzene-heptane-methanol-
water (40:60:70:30) (system I) as described by
Bush (11). The amount of "C in each peak in the
paper chromatograms was estimated with a Van-
guard Autoscanner 880 equipped with an auto-
matic data recorder and expressed as the percentage
of the total radioactivity on the chromatogram.
The reaction products were eluted separately and
further chromatographed in the following sys-
tems: isooctane-toluene-methanol-water (25 :75:
80:20) (system II) and benzene-methanol-water
(100:55:45) (system III) (12). The R, values were
compared to those of reference compounds (Table
1).
Following chromatography each peak was
eluted separately, diluted with carrier, and the
specific activity determined (Table 2). After
crystallization from different solvents, 300—1000
cg of crystals were weighed on a Cahn Gram
Electrobalance; radioactivity was measured in a
Tri-Carb liquid scintillation counter, Model 314
EX with a counting efficiency for 4C of 43%.
4
RE STILTS
Characterization of metabolites—Three peaks
of radioactivity were detected in the chromat-
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TABLE 2
A. Identification of estrone-4-'4C
Recrystallized estrone (52.9 mg) was added to
an aliquot containing 6.37 )< 10 dpm of 14C eluted
from the area of Peak 3 after the incubation of
estradiol-4-'4C with foreskin. The calculated spe
cific activity was 324 dpm/pmole.
Solvents
Acetone-hexane
Methylerie chloride-
hexane
Chloroform-hexane
No. of
ci-ystn
1
1
1
Amount
recovered
(mg)
48.5
14
10.5
SA
(dpm/
imole)
276
273
281
ograms after incubation of foreskin, abdominal
skin, or vaginal mucosa with either estradiol-14C
or estrone-'4C. Figure 1 shows the results ob-
tained in an experiment with foreskin. The
fl, of peak 1 was similar to but not identical
with that of estriol (Table 1). Repeated
chromatography and crystallization of the
radioactive product in peak 1 with carrier
estriol indicated they were different com-
pounds. This peak represented 2—5% of the
radioactivity in the chromatogram and was
also found in control experiments in which
skin was either boiled or omitted. Similar
findings were reported by other investigators
(13) and were considered to be non-specific
adsorption at the origin of the chromatograrn.
The mobility of peak 2 corresponded to
that of 17,6-estradiol (Table 1) and was found
after incubations with estrone-14C as the sub-
strate. The mobility of peak 3 corresponded
to that of estrone, and appeared when estra-
dioI-4C was used as the substrate. Identifi-
cation of these metabolites as 17,6-estradiol
and estrone, respectively, was established by
reverse isotopic dilution (Table 2).
Effect of duration of incubation—The inter-
conversion of estradiol and estrone in foreskin
was studied for periods tip to six hours. The
conversion of estradiol to estrone occurred at
a rate several times greater than the reverse
reaction throughout this period. The data
shown in Figure 2 indicate that 5 hours of
incubation gave sufficient amounts of metabo-
lites to permit characterization of the reaction
products.
TABLE 1
R1 values
Compound
B. Identification of 17fl-eslradiol-4-'4C
Recrystallized 17j3-estradiol (37 mg) was added
to an aliquot containing 1.61 )< 10 of '4C eluted
from the area of Peak 2 after the incubation of
estrone-4-'4C with foreskin. The calculated specific
activity was 119 dpm/pmole.
Solvents
AmountNo. o recovered
crystn (mg)
SA
(dpm/
imoIe)
Acetone-hexane 1 22 130
Methylene chloride- 2 17 112
hexane
Acetone-hexane 1 13 118
Chloroform-hexane 1 10 110
Acetone-hexane 1 6 106
Benzene-hexane 1 5 107
Solvent systems
II III
Peak 1 0.03 0.06 0.12
Estriol 0.00 0.01 0.19
Peak 2 0.21 0.63 0.88
17$-Estradiol 0.21 0.65 0.85
Peak 3 0.59 0.94 0.95
Estrone 0.56 0.91 0.95
Effect of weight of tissue incubated—The
conversion of estradiol to estrone was propor-
tional to the amount of foreskin incubated up
to 200 mg per S ml of incubation mixture
(Fig. 3).
Relative rates of the interconversion of
estradiol and estrone—In 5 hours, 200 mg of
neonatal foreskin without addition of pyridine
nucleotides converted 43.4% of the incubated
estradiol to estrone, but only 3.4% of estrone
to estradiol (Table 3). Under similar condi-
tions abdominal skin converted 11.6% of the
incubated estradiol to estrone and 2.7% of
estrone to estradiol. In vaginal mucosa, how-
ever, the major reaction was in the opposite
direction; 18.3% of the incubated estrone
was converted to estradiol, whereas only 5.6%
of the estradiol was metabolized to estrone.
The age of the patient had no apparent in-
fluence on the rates of interconversion; neither
Solvent system I; henzerie: heptane : methanol: -
water—40:6070:30. (10).
Solvent system II; iso-octane: tol uene : metha-
nol:water—25:75:8020. (11).
Solvent system III; benzene: methanol: water—
100:55:45. (11).
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Fru. 1. Tracings of paper chrornatograms (system I) from Vanguard Autoscanner 880.
The peaks designated by the numbers and 1?, values are described in the text and Table 1.
The interconversion of estradiol and estrone is demonstrated in these tracings after 5 hours
of incubation with foreskin; controls with boiled foreskin showed no activity. When the
chromatogranis were scanned on a higher scale, single symmetrical peaks were observed.
did it matter if a woman was pre- or post-
menopausal.
Influence of cofactors—The influence of
pyridine nucleotides in these reactions was
demonstrated (Table 4). Specimens of fore-
skin frozen at —67° C for 75 minutes and
then thawed lost virtually all activity in the
interconversion of estradiol and estrone. The
activity was restored upon the addition of
cofactors. In the conversion of estradiol to
estrone, addition of NAD or NADH resulted
ii a comparable increase. In the conversion of
estrone to estradiol, only NADH was active.
NADP and NADPH were less effective.
The effect of cofactors was also studied
with fresh tissues. The additioii of S tmoles
of NAP to the incubatioi mixture significantly
increased the oxidation of estradiol to estrone
in vaginal mucosa while in foreskin and ab-
dominal skin a smaller but not statistically
significant increase was seen (Table 3). Un
the other hand, the addition of S p.moles of
NADH significantly increased the reductioi
of estrone to estradiol in foreskin and ab-
dominal skin but not in vaginal mucosa.
Epidermal versus dermal activity—The re-
sults in Table 3 suggest that foreskin is ap-
proximately four times as active as abdominal
skin in converting estradiol to estrone. In an
attempt to explain this difference, the relative
size and enzymatic activity of the epidermal
and dermal compartments were determined.
Foreskin and abdominal skin specimens were
warmed at 57° C in 0.9% NaC1 for two
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iniiiutes, after winch the epidermis could be
easily and completely peeled off the dermis.
Histologic sections of the separated tissues
showed that the epidermal portion contained
no dennis, and that the epidermal appendages,
i.e., sweat glands and hair follicies, remained
in the dermis. The separated tissues were in-
cubated with estradiol-14C and NAD. From
the data in Table 5 it can be caiculated that
about 60% of the enzymic activity remains
in the separated tissues. The data indicate
that epidermis is more active than dermis in
converting estradiol to estrone, and the relative
amounts of epidermis and dermis vary at
different body sites. In the foreskin the ratio
of epidermis to dermis was 1:3 (wet weight),
while in abdominal skin it was 1:11. Heat-
separated epidermis from foreskin and ab-
dominai skin were similar in activity per rng
tissue. It appears that the larger ratio of
epidermis to dermis in foreskin accounts for
the observed greater activity of foreskin.
Control of microbial contamination—In con-
trol experiments with foreskin, antibiotics
(streptornycin, 500 tg, and penicillin, 500
units) were added to the incubation mixtures.
At the end of the incubations, aliquots of the
incubate were cultured for bacteria and
fungi; the results were negative. The distri-
bution of 14C on the chromatograms obtained
in these experiments was indistinguishable
70
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FIG. 3 Different weights of foreskin were incu-
bated with estradioP4C and cofactor under opti-
mum conditions. The conversion of estradiol to
estrone was proportional to the amount of foreskin
up to 200 mg.
from that obtained in experiments without the
addition of antibiotics. Thus bacterial growth
was ruled out as a cause of the observed
metabolic changes.
DISCUSSION
These experiments demonstrated active in-
terconversion of estrone and estradiol in
human skin and vaginal mucosa. It is interest-
ing that the predominant product in vaginal
mucosa is estradiol, but in abdominal skin
and foreskin the major product is estrone. The
responsiveness of vaginal mucosa to estrogenic
stimulation has long been known. One may
speculate that this predominant conversion of
estrone to estradioi in the vaginal mucosa may
be reiated to the physioiogical response of
vagina to estradiol. Stone and Martin (14)
found that in the vagina of ovariectomized
mice, estrone is metabolized to estradiol but
estradiol is not converted to estrone. Jensen
and Jacobson (15), using tritiated estrogens of
high specific activity, found that in the im-
mature rat estradiol is retained in the uterus
and vagina in preference to estrone. They
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Fw. 2. Foreskin was incubated with either es-
tradiol-14C or estrone-'4C and appropriate cofactors
for varying periods of time. The conversion of
estradiol to estrone occurred at a rate several
times greater than the reverse reaction during this
interval.
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TABLE 3
Interconversion of estradiol (E2) and estrone (E1) at different si/cs
Tissue (200 mg)
E1 (% conversion) E1 E2 (% conversion)
No added cofactor NADI-I (5Mmoles)No added cofactor NAB (5Mmoles)
Neonatal Foreskin
Abdominal Skin
Vaginal Mucosa
43.4 (3)
11.6 (3)
5.6 (7)*
52.3 (7) 3.4 (3)
15.0 (5) 2.7 (4)
7.3 (7) 18.3 (7)
7.0 (5)
4.9 (5)
16.5 (7)
Number of experiments
Standard Deviation
* The data for differences in reactions with and without added cofactor were analyzed statistically
by the two sample T test, and by the one sample T test for matched pairs. Only those values in italics
were significantly different at p < 0.05 by either test. Vaginal mitcosa and abdominal skin data were
significant by matched pair analysis and foreskin data by the two sample T test.
further found that the estradiol retained in
the uterus was not appreciably metabolized
to estrone whereas in "non-target" tissues like
liver and blood (13) estradiol is converted to
estrone. The results of our studies on the
conversion of estrone to estradiol in vaginal
inucosa and estradiol to estroiw in abdominal
skin and foreskin are in agreement with the
above studies on target and non-target tis-
sues. In a recent study by Sweat et al. (16)
the interconversion of estradiol and estrone
was also found in human endometriurn and
myornetrium; the major conversion, however,
was of estradiol to estrone.
Migeon et al. (13) have reported that red
blood cells are capable of interconverting
estrogens, but at a rate substantially slower
then the rate observed in skin. Furthermore,
most of the enzyme activity found in our
studies was in the avascular epidermis of skin
or vaginal mucosa. Therefore, it is not likely
that the relatively small intravascular com-
ponents of the skin were responsible for signifi-
cant enzyme activity.
It has been shown that hurnai skin is
capable of converting testosterone to andros-
tenedione and vice versa (4), an interconversion
similar to that of estradiol and estrone.
Langer et at. (17) found that the human
placental estradiol-17/3 dehydrogenase was
specific for estradiol and did not affect
testosterone. It would be interesting to know
whether the same enzyme in human skin is
involved in the dehydrogenation at the 17/3
position in both testosterone and estradiol.
The requirement for pyridine nucleotides for
the metabolism of estrogens in human skin
was demonstrated by the experiment with
frozen and thawed skin (Table 4), in which
little interconversion of estrone and estradiol
occurred without the addition of these co-
factors. Addition of either NAD or NADH
was equally effective in restoring the oxida-
tion of estradiol to estrone in foreskin. The
added NADH was possibly oxidized by other
metabolic systems to NAD which was then
utilized for the oxidation of estradiol to estrone.
Added MAD was ineffective in stimulating
the reduction of estrone, indicating that enough
NADH may not have been generated from
NAD for the reaction. The data shown in
Table 4 indicate that NADP and NADPH
also enhanced the reaction, although not as
effectively as NAD and NADH. The cofactor
dependence of estradiol-17/3 dehydrogenase
from human red blood cells (13) and placenta
(18—21) has been extensively investigated.
The loss of enzymatic activity after the
tissue was frozen and thawed may be a result
of several events. The pyridine nucleotides
in the tissue might have deteriorated or have
been converted to inhibitors (22). Jarabak
et cii. (23) showed that human placental
17/3-hydroxysteroid dehydrogenase is iriac-
tivated by cold and that it can be partially
protected by pyridine nucleotide or 17/3-
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estradiol at low concentrations. Cold inactiva-
tion of the enzyme in skin and reactivation
by the pyridine nucleotide could explain
the results observed after freezing and thaw-
ing as described in this paper.
A novel observation was made with fresh
tissues (Table 3): the oxidation of estradiol
to estrone was significantly enhanced by the
addition of NAD in vaginal mucosa, but not
in foreskin and abdominal skin. Significant
increase in activity resulting from the addition
of cofactors thus appeared only in the direc-
tion opposite to the predominant reactions.
These observations are interesting but difficult
to interpret without further data regarding
such factors as the endogenous level of
pyridine nucleotides in the tissue, the amount
of added pyridine nucleotides actually pene-
TABLE 4
Effect of cofactors on interconversion of esirone
(B1) and 17j3-estracliol (B2)
A. B2 —* B1
Tissuea Cofactor added
Fresh
Boi1ed'
Frozen and thawedc
none
NAD
NAD
none
NAD
NADH
NADP
NADPH
48
69
0
6
32
33
11
8
B. B1 —. B2
Tissue Cofactor added
Fresh
Boiledb
Frozen and thawecfz
none
NADH
NADH
none
NAD
NADH
NADP
NADPH
4.2
6.4
0
1.8
0.8
10.1
3.6
6.2
a Reaction mixture for each experiment con-
tained 200 mg of minced foreskin.
b Control specimens were boiled for 20 minutes
in buffer.
Specimens were frozen at —67° C for 75 min-
utes and then allowed to thaw at room tempera-
ture.
TABLE 5
Conversion of estradiol to esirone in epidermis
and dermis
Weight distri-
bution (% of
whole skin)
Conversion
per mg tissue
Foreskin
Heat-separated
epidermis 25 032
Heat-separated dermis 75 0.08
Fresh whole skin 100 0.26
Abdominal skin
Heat-separated
epidermis 8 0.37
Heat-separated dermis 92 0.024
Fresh whole skin 100 0.075
Epidermis and dermis were separated by heat-
ing in 57° C saline for two minutes. The weights
of dermis and epidermis were expressed in per-
centage of whole skin. The results shown are the
average of three experiments with foreskin and
two with abdominal skin.
trating the skin and cells, and the rates of
the redox reactions involved.
Our data (Table 3) indicate that foreskin
is more active than either abdominal skin or
vaginal mucosa in metabolizing estrogens. The
higher enzymatic activity in neonatal fore-
skin may be due to enzyme induction in utero
when the fetus is exposed to high levels of
maternal estrogens, or may be simply due to
greater enzyme activity in young skin. The
most likely explanation for this difference,
however, is dependent on the fact that fore-
skin contains relatively more epidermis than
abdominal skin. In experiments in which the
epidermis and dennis were separated by heat-
ing at 57° C, the epidermis was several fold
more active per unit weight than dermis (Ta-
ble 5). The epidermis, highly cellular com-
pared to dermis, is apparently the site of
most biochemical activity in skin. It is not
clear if the enzymic activity present in the
dermis was contributed by epithelial ap-
pendages remaining in the dermis after re-
moval of the epidermis. Sweat et al. (16) ob-
served that the rate of estradiol metabolism
in human myometrium was Mo that of
endometrium. The situation in skin and uterus
appears to be analogous in that the highly
cellular epidermis and endometrium are much
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more active metabolically than the less cel-
lular dermis and myometrium.
The presence of enzymatic systems in skin
which metabolize steroid hormones, i.e., estro-
gens, androgens and corticosteroids, is now
well established. By virtue of its being one
of the largest organs in the body (24), skin
may significantly influence the general body
level of these hormones. How these metabolic
pathways influence physiologic processes in
skin is a problem yet to be explored.
SUMMARY
1. Interconversion of estrone-4-14C and 17,2-
estradiol-4-14C was demonstrated in vitro in
specimens of neonatal foreskin, abdominal
skin and vaginal inucosa.
2. The major reaction was oxidation of
estradiol to estrone in foreskin and abdominal
skin, but the reverse is true in vaginal mucosa.
3. Freezing and thawing skin specimens re-
sulted in a loss of estrogen metabolizing ac-
tivity which was, however, restored by the
addition of NAD or NADH in the incuba-
tion medium. Addition of pyridine iucleo—
tides to incubation mixtures of fresh tissue
significantly enhanced the oxidization of
estradiol by vaginal inucosa and the reduc-
tion of estrone by foreskin and abdominal
skin, but not the reverse reactions.
4. Foreskin is more active than abdominal
skin in oxidizing estradiol to estrone. This
greater activity in foreskin may be attributed
to its relatively larger content of epidermis,
\sThich was shown to be more active in these
reactions than dermis.
REFERENCES
1. Haiprin, K. M. and Akira, 0.: Glucose and gly-
cogen metabolism in the human epidermis. J.
Invest. Derm., 46: 43, 1966.
2. Kandutsch, A.: Sterol metabolism in skin and
epidermis. P. 493, The Epidermis. Eds., Mon-
tagna, W. and Lobitz, W. C. Jr Academic
Press, New York, 1964.
3. Hsia, S. L. and Hao, Y. L.: Metabolic trans-
formations of cortisol-4-14C in human skin.
Biochemistry, 5: 1469, 1966.
4. Gornez, E. C. and Hsia, S. L.: in vitro metabo-
lism of testosterone-424C and a4-andro-
stene-3,17-dione-4-14C in human skin. Bio-
chemistry, 7: 24, 1968.
5. Adachi, K., Lewis, C. and Hershey, F. B.:
Enzymes of amino acid metabolism in nor-
mal human skin. J. Invest. Derm., 49: 240,
1967.
6. Frost, P., Weinstein, G. D. and Hsia, S. L.:
Metabolism of estradiol-17fl and estrone in
human skin. J. Invest. Derm., 46: 584, 1966.
7. Friedberg, I. M., Fine, I. H. and Cordelle,
F. H.: Cell-free protein synthesis in mam-
malian skin. J. Invest. Derin., 48: 55, 1967.
8. Wotiz, H. H., Mescon, II., Doppel, H. and
Lemon, H. M.: The in vitro metabolism of
testosterone by human skin. J. Invest. Derm.,
26: 113, 1956.
9. Rongone, E. L.: Testosterone metabolism by
human male mammary skin. Steroids, 7:
489, 1966.
10. Gallegos, A. J. and Berliner, D. L.: Transfor-
mation and conjugation of dehydroepian-
drosterone by human skin. J. Clin. End.
Metab., 27: 1214, 1967.
11. Bush, I. E.: Methods of paper chromatography
of steroids applicable to the study of ster-
oids in mammalian blood and tissues. Bio-
chem. J., 50: 370, 1952.
12. Migeon, L. J., Wall, P. E. and Bertrand, J.:
Some aspects of the metabolism of 16-C14—
estrone in normal individuals. J. Clin. In-
vest., 38: 619, 1959.
13. Migeon, C. J., Lescure, 0. L., Zinkham, W. H.
and Sidhury, J. B. Jr.: In vitro interconver-
sion of 16-C'4-estrone and 16-C14-estradiol-
17p by erythrocytes from normal subjects
and from subjects with a deficiency of red
cell glueose-6-phosphate dehydrogenase ac-
tivity. J. Clin. Invest., 41: 2025, 1962.
14. Stone, G. M. and Martin, L.: Radioactive
compounds in the vagina of the ovariecto-
mized mouse after local application of ors-
tradiol-6 7,-all and oestrone-6 ,7, -3H. Ster—
oids,5: 791, 1965.
15. Jensen, E. V. and Jacobson, H. I.: Basic guides
to the mechanism of estrogen action. Bee.
Prog. Horm. Res., 18: 387, 1962.
16. Sweat, M. L., Bryson, M. J. and Young, B. B.:
Metabolism of 17fl-estradiol and estrone by
human proliferative endometriurn and myo—
metrium. Endocrinology, 81: 167, 1967.
17. Langer, L. J., Alexander, J. A. and Engel, L.
14.: Human placental estradiol-17j3 dehy—
drogenase. J. Biol. Chern., 234: 2609, 1959.
18. Talalay, P. and Williams-Ashman, H. G.: Par-
ticipation of steroid hormones in the enzy-
matic transfer of hydrogen. Recent. Prog.
Horm. Res., 16: 1, 1960.
19. Langer, L. J. and Engel, L. L.: Human pla-
cental estradiol-173 dehydrogenase. J. Biol.
Chem., 233: 583, 1958.
20. Hagerman, D. D. and Villee, C. A.: Separation
of human placental estrogen-sensitive trans—
hydrogenase from estradiol-17p dehydrogen-
ase. J. Biol. Chem., 234: 2031, 1959.
21. Kellogg, D. A. and Glenner, G. G.: Histochem-
ical localization of human term placental
17-estradiol dehydrogenases: implications
for the transhydrogenase reaction. Nature,
187: 763, 1960.
22. Faweett, C. P., Ciotti, M. M. and Kaplan,
N .0.: Inhibition of dehydrogenase reactions
by a substance formed from reduced diphos-
phopyridine nucleotide. Biochim. Biophys.
Acta, 54: 210, 1961.
23. Jarabak, J., Seeds, A. E., Jr. and Talalay, P.:
Reversible cold inactivation of a 17fl-hy-
droxysteroid dehydrogenase of human pla-
centa: protective effect of glycerol. Biochem-
istry, 5: 1269, 1966.
24. Montagna, W.: P. 2, The Structure and Func-
tion of Skin. Academic Press, New York,
1956.
